Nabanita Nawar - Concepedia

Author

Nabanita Nawar

University of Toronto

Also Known As

Nabanita Nawar, Nawar, Nabanita

Publications

277

Citations

H-Index

Concepts

All Affiliations

University of Toronto

About

Nabanita Nawar is an author at University of Toronto specializing in medicine, drug discovery, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	78
2	Health Sciences	1	1	40
3	Natural Sciences	1	1	38
4	Biochemistry	1	1	38
5	Biomolecular Engineering	1	1	38

Nabanita Nawar

Publications

209

Citations

H-Index

Page 1

	Year	Citations
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia Krimo Toutah, Nabanita Nawar, Sanna Timonen, Journal of Medicinal Chemistry	2021	43
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf, European Journal of Medicinal Chemistry Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	2020	40
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting Muhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar, Journal of Medicinal Chemistry Combinatorial ChemistryHistone DeacetylasesMedicinal ChemistryDrug TargetFavors Hdac8 Selectivity	2020	38
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma Nabanita Nawar, Shazreh Bukhari, Ashley Adile, Journal of Medicinal Chemistry	2022	29
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar, Journal of Medicinal Chemistry	2021	26
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia Andrew E. Shouksmith, Justyna M. Gawel, Nabanita Nawar, ACS Medicinal Chemistry Letters	2019	20
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular Dystrophy Yasir S. Raouf, Abootaleb Sedighi, Mulu Geletu, Journal of Medicinal Chemistry	2023	13

Page 1